A 60-Year-Old Man With Early Relapse Multiple Myeloma

Aimee Merino, MD, discusses how the treatment decision for a 60-year-old patient with early relapse/refractory multiple myeloma, involving chimeric antigen receptor (CAR) T-cell therapy, aligns with the goals of therapy while exploring alternative treatment options and considerations for high-risk patients.

Now Viewing

EP: 1.A 60-Year-Old Man With Early Relapse Multiple Myeloma

Video content above is prompted by the following:

1. Please share your impressions of the patient case and goals of therapy.

• Do you agree with the treatment decision, why or why not?

Recent Videos